Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:focusesOn |
autoimmune diseases
epigenetic therapies |
| gptkbp:foundedIn |
2013
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Padlock Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
PAD inhibitors
|
| gptkbp:website |
https://www.padlocktherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Jean-François_Formela
|
| gptkbp:bfsLayer |
7
|